Your claim doesn’t make sense any more to me than the claim in the article. Costly regulation should simply drive the cost of generics up until they are profitable at a new price.
Your claim is that the market cannot deal with increased costs of a product.
> Your claim is that the market cannot deal with increased costs of a product.
which might be true, if the person cannot afford it at this higher price, despite needing the medication. For example, the gov't subsidies for these people aren't high enough.
Despite what people might think, medication and healthcare is not absolutely inelastic.
Your claim is that the market cannot deal with increased costs of a product.